LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Kodu・Aktsiate loetelu・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Avatud

SektorTervishoid

1.68 -0.59

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.6600000000000001

Max

1.78

Põhinäitajad
By Trading Economics
Sissetulek	-2.8M -16M
Müük	-8.7M 5.5M
Kasumimarginaal	-282.723
Töötajad	103
EBITDA	-4.2M -15M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+122.67% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. mai 2026

Turustatistika
By TradingEconomics
Turukapital	60M 712M
Eelmine avamishind	2.27
Eelmine sulgemishind	1.68

Uudiste sentiment

By Acuity

34%

66%

86 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.6863 / 0.72 Toetus ja vastupanu

Lexicon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. märts 2026, 23:12 UTC

Kuumad aktsiad

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12. märts 2026, 22:15 UTC

Tulu

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12. märts 2026, 21:42 UTC

Uudisväärsed sündmused

Stryker Says Cyberattack Disruption Is Continuing

12. märts 2026, 21:29 UTC

Uudisväärsed sündmused

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12. märts 2026, 21:27 UTC

Tulu

Adobe CEO to Depart as AI Boosts Sales -- Update

12. märts 2026, 20:46 UTC

Tulu

Adobe Posts Higher Sales With CEO Set to Depart

12. märts 2026, 20:21 UTC

Uudisväärsed sündmused

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12. märts 2026, 23:57 UTC

Market Talk

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12. märts 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. märts 2026, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12. märts 2026, 22:13 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

12. märts 2026, 22:13 UTC

Market Talk

Tulu

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12. märts 2026, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12. märts 2026, 21:04 UTC

Tulu

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Sales $865M >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Net $558.3M >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12. märts 2026, 20:57 UTC

Market Talk

Uudisväärsed sündmused

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12. märts 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. märts 2026, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12. märts 2026, 20:10 UTC

Tulu

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12. märts 2026, 20:05 UTC

Tulu

Adobe 1Q Rev $6.4B >ADBE

12. märts 2026, 20:05 UTC

Tulu

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Võrdlus sarnastega

Hinnamuutus

Lexicon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

122.67% tõus

12 kuu keskmine prognoos

Keskmine 3.83 USD 122.67%

Kõrge 6 USD

Madal 1 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Lexicon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Lexicon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.6863 / 0.72Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bearish event.

Sentiment

By Acuity

86 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.